Wolfe Research Downgrades Salesforce to Peer Perform
Wolfe Research analyst Alex Zukin downgrades Salesforce (NYSE:CRM) from Outperform to Peer Perform.
Wolfe Research Downgrades Edwards Lifesciences to Peer Perform
Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.
Wedbush Downgrades Cheesecake Factory to Neutral, Lowers Price Target to $35
Wedbush analyst Nick Setyan downgrades Cheesecake Factory (NASDAQ:CAKE) from Outperform to Neutral and lowers the price target from $37 to $35.
HC Wainwright & Co. Downgrades SQZ Biotechnologies to Neutral
HC Wainwright & Co. analyst Emily Bodnar downgrades SQZ Biotechnologies (NYSE:SQZ) from Buy to Neutral.
Why This PagSeguro Analyst Is Turning Bearish
PagSeguro Digital Ltd’s (NYSE: PAGS) stock has underperformed this year and could be close to the bottom. Yet there are still downside risks to the consensus estimates, according to Goldman Sachs.
Benzinga’s Top Ratings Upgrades, Downgrades For December 1, 2022
Upgrades Northcoast Research upgraded the previous rating for SpartanNash Co (NASDAQ:SPTN) from Neutral to Buy. SpartanNash earned $0.55…
CL King Downgrades G-III Apparel Group to Neutral
CL King analyst Steven Marotta downgrades G-III Apparel Group (NASDAQ:GIII) from Buy to Neutral.
Lake Street Downgrades OncoCyte to Hold, Lowers Price Target to $0.5
Lake Street analyst Thomas Flaten downgrades OncoCyte (NASDAQ:OCX) from Buy to Hold and lowers the price target from $3 to $0.5.
Morgan Stanley Downgrades Lufax Holding to Equal-Weight, Lowers Price Target to $1.52
Morgan Stanley analyst Richard Xu downgrades Lufax Holding (NYSE:LU) from Overweight to Equal-Weight and lowers the price target from $7 to $1.52.
Consumer Edge Research Downgrades B&G Foods to Underweight, Announces $9 Price Target
Consumer Edge Research analyst Connor Rattigan downgrades B&G Foods (NYSE:BGS) from Equal-Weight to Underweight and announces $9 price target.